Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Pamidronate for the Prevention of Heterotopic Ossification

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
FAG (Freie Medizinische Gesellschaft)
Information provided by:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT00262392
First received: December 5, 2005
Last updated: March 9, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: June 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)